Prognostic factors in patients with differentiated thyroid carcinoma.

T Steinmüller, J Klupp, N Rayes, F Ulrich, S Jonas, K J Gräf, P Neuhaus
{"title":"Prognostic factors in patients with differentiated thyroid carcinoma.","authors":"T Steinmüller,&nbsp;J Klupp,&nbsp;N Rayes,&nbsp;F Ulrich,&nbsp;S Jonas,&nbsp;K J Gräf,&nbsp;P Neuhaus","doi":"10.1080/110241500750009663","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To study the prognostic factors in patients with differentiated thyroid carcinoma.</p><p><strong>Design: </strong>Retrospective analysis.</p><p><strong>Setting: </strong>University hospital, Germany.</p><p><strong>Patients: </strong>139 consecutive patients who underwent surgery for follicular (n = 42) and papillary thyroid carcinoma (n = 97).</p><p><strong>Main outcome measures: </strong>Survival rate, type of operation (systematic lymphadenectomy or no lymphadenectomy).</p><p><strong>Results: </strong>Median observation time was 72 months (range 1-203). The 5 and 10 year survival rates in patients with papillary carcinoma were 92% and 89% respectively, and in those with follicular carcinoma 88% and 80%, respectively. Prognostic factors for papillary carcinoma were distant metastases, age, and extrathyroidal growth, and for follicular carcinoma they were distant metastases, extrathyroidal extension, and multifocal growth. The Union International contre le Cancer and European Organisation for Research and Treatment of Cancer scores and the age, grade, extent and size score were all highly significant. The extent of lymphadenectomy, primary or secondary thyroidectomy, and partial or total thyroidectomy did not influence survival.</p><p><strong>Conclusion: </strong>Staging and score systems may be helpful in calculating prognosis in differentiated thyroid carcinoma, but the benefit of systematic lymphadenectomy remains controversial.</p>","PeriodicalId":22411,"journal":{"name":"The European journal of surgery = Acta chirurgica","volume":"166 1","pages":"29-33"},"PeriodicalIF":0.0000,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241500750009663","citationCount":"85","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The European journal of surgery = Acta chirurgica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/110241500750009663","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 85

Abstract

Objective: To study the prognostic factors in patients with differentiated thyroid carcinoma.

Design: Retrospective analysis.

Setting: University hospital, Germany.

Patients: 139 consecutive patients who underwent surgery for follicular (n = 42) and papillary thyroid carcinoma (n = 97).

Main outcome measures: Survival rate, type of operation (systematic lymphadenectomy or no lymphadenectomy).

Results: Median observation time was 72 months (range 1-203). The 5 and 10 year survival rates in patients with papillary carcinoma were 92% and 89% respectively, and in those with follicular carcinoma 88% and 80%, respectively. Prognostic factors for papillary carcinoma were distant metastases, age, and extrathyroidal growth, and for follicular carcinoma they were distant metastases, extrathyroidal extension, and multifocal growth. The Union International contre le Cancer and European Organisation for Research and Treatment of Cancer scores and the age, grade, extent and size score were all highly significant. The extent of lymphadenectomy, primary or secondary thyroidectomy, and partial or total thyroidectomy did not influence survival.

Conclusion: Staging and score systems may be helpful in calculating prognosis in differentiated thyroid carcinoma, but the benefit of systematic lymphadenectomy remains controversial.

分化型甲状腺癌患者预后因素分析。
目的:探讨分化型甲状腺癌患者预后的影响因素。设计:回顾性分析。地点:德国大学医院。患者:139例连续接受滤泡性甲状腺癌(42例)和乳头状甲状腺癌(97例)手术的患者。主要观察指标:生存率、手术类型(全身淋巴结切除术或不进行淋巴结切除术)。结果:中位观察时间为72个月(范围1 ~ 203个月)。乳头状癌患者的5年和10年生存率分别为92%和89%,滤泡癌患者的5年和10年生存率分别为88%和80%。乳头状癌的预后因素为远处转移、年龄和甲状腺外生长,滤泡癌的预后因素为远处转移、甲状腺外扩展和多灶性生长。国际癌症联盟和欧洲癌症研究与治疗组织的评分以及年龄,分级,程度和大小评分都非常显著。淋巴结切除术、原发性或继发性甲状腺切除术、部分或全部甲状腺切除术的程度对生存率没有影响。结论:分期和评分系统可能有助于计算分化型甲状腺癌的预后,但系统性淋巴结切除术的益处仍存在争议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信